NCT05209321

Completed

Predictors of Malnutrition in Patients With Haematological C...

Jens Rikardt Andersen Source

Other study identifiers

Sponsor study identifier

504-0226

Study Type

observational

Actual enrollment (reported)

62

Locations

1 country

Sites

1

Timeline

Study Start

April 1, 2021

Actual (reported)

Primary Completion

July 15, 2021

Actual (reported)

Study Completion

October 4, 2021

Actual (reported)

Brief Summary

The primary purpose of this study is to conduct an exploratory study of which predictors are most significant for LBM loss in patients with lymphoma. Patients are measured by weight and bio impedance and furthermore, their physical activity, nutritional status, diet and quality of life during the course are estimated. This is done in order to determine any changes in the aforementioned factors during the course of the cancer treatment that may have a bearing on the loss of LBM.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 62 participants
Study completion date: October 4, 2021
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
April 1, 2021
Actual (reported)
Primary Completion
July 15, 2021
Actual (reported)
Study Completion
October 4, 2021
Actual (reported)
First Submitted
January 12, 2022
Actual (reported)
First Posted
January 26, 2022
Actual (reported)

Last Updated: November 4, 2022
Status Verified: November 2022
Last Update Submitted: November 2, 2022

Conditions

Lymphoma Malnutrition

Outcome Measures

Primary Outcomes (1)

Loss of Lean Body Mass
Lean Body Mass measured by bioimpedance
2 months

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients over the age of 18 years, with haematological cancer, receiving myelosuppressive chemotherapy.

You may qualify if:

Patients with haematological cancer

Sponsors & Collaborators

Jens Rikardt Andersen
Otherlead

Study Sites (1)

Dept Haematology, Roskilde University Hospital

Roskilde, 4000, Denmark

MeSH Terms

Conditions

MalnutritionLymphoma

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

Jens R Andersen, MD,MPA
University of Copenhagen
STUDY DIRECTOR

Enrollment

62 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Target Duration: 2 Months
Sponsor Type: OTHER
Responsible Party: SPONSOR INVESTIGATOR
PI Title: Assoc Prof

Study Record Dates

First Submitted

January 12, 2022

First Posted

January 26, 2022

Study Start

April 1, 2021

Actual (reported)

NCT07881003

Prevalence and Associated Factors of GLIM-Defined Malnutrition Among Hospitalized Older Adults

Completed

NCT04958447

Nutritional Management in Respiratory Critically Ill Patients -an Observational Study in Mainland China

Unknown

NCT06009198

Nutritional, and WASH Related Education Intervention to Address Malnutrition of Early Adolescents in Pakistan

Not ApplicableCompleted

NCT05815914

Nutritional Support and Telemedicine

Not ApplicableUnknown

NCT04417803

Interest of Individual Biomarkers From the Identification of Tumor Genotype by High-throughput Molecular Techniques

Not ApplicableRecruiting

NCT04926597

Effect of Continued Nutritional Support at Hospital Discharge on Mortality, Frailty, Functional Outcomes and Recovery

Not ApplicableRecruiting

Patients receiving myelosuppressive chemotherapy for haematological disease

Adult patients

You may not qualify if:

Patients who cannot understand and speak Danish or English
Pregnant and breastfeeding
Patients who suffer from dementia

Contact the study team to confirm eligibility.

Primary Completion

July 15, 2021

Actual (reported)

Study Completion

October 4, 2021

Actual (reported)

Last Updated

November 4, 2022

Record last verified: 2022-11

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT05209321
Data provider: ClinicalTrials.gov
Source updated: 2022-11-04
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:37:00 UTC

Locations

DK(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations